262 related articles for article (PubMed ID: 10477702)
1. Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice.
Ailles LE; Gerhard B; Kawagoe H; Hogge DE
Blood; 1999 Sep; 94(5):1761-72. PubMed ID: 10477702
[TBL] [Abstract][Full Text] [Related]
2. Retroviral marking of acute myelogenous leukemia progenitors that initiate long-term culture and growth in immunodeficient mice.
Ailles LE; Humphries RK; Thomas TE; Hogge DE
Exp Hematol; 1999 Nov; 27(11):1609-20. PubMed ID: 10560908
[TBL] [Abstract][Full Text] [Related]
3. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.
Feuring-Buske M; Gerhard B; Cashman J; Humphries RK; Eaves CJ; Hogge DE
Leukemia; 2003 Apr; 17(4):760-3. PubMed ID: 12682634
[TBL] [Abstract][Full Text] [Related]
4. A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors.
Feuring-Buske M; Frankel AE; Alexander RL; Gerhard B; Hogge DE
Cancer Res; 2002 Mar; 62(6):1730-6. PubMed ID: 11912147
[TBL] [Abstract][Full Text] [Related]
5. Detection and characterization of primitive malignant and normal progenitors in patients with acute myelogenous leukemia using long-term coculture with supportive feeder layers and cytokines.
Ailles LE; Gerhard B; Hogge DE
Blood; 1997 Oct; 90(7):2555-64. PubMed ID: 9326221
[TBL] [Abstract][Full Text] [Related]
6. Variable cytotoxicity of diphtheria toxin 388-granulocyte-macrophage colony-stimulating factor fusion protein for acute myelogenous leukemia stem cells.
Feuring-Buske M; Frankel A; Gerhard B; Hogge D
Exp Hematol; 2000 Dec; 28(12):1390-400. PubMed ID: 11146161
[TBL] [Abstract][Full Text] [Related]
7. Identification of variables determining the engraftment potential of human acute myeloid leukemia in the immunodeficient NOD/SCID human chimera model.
Rombouts WJ; Martens AC; Ploemacher RE
Leukemia; 2000 May; 14(5):889-97. PubMed ID: 10803522
[TBL] [Abstract][Full Text] [Related]
8. Cytokine responsiveness of primitive progenitors in acute myelogenous leukemia.
Hogge DE; Ailles LE; Gerhard B
Leukemia; 1997 Dec; 11(12):2220-1. PubMed ID: 9447847
[TBL] [Abstract][Full Text] [Related]
9. Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML).
Guan Y; Gerhard B; Hogge DE
Blood; 2003 Apr; 101(8):3142-9. PubMed ID: 12468427
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a hierarchy in human acute myeloid leukemia progenitor cells.
Sutherland HJ; Blair A; Zapf RW
Blood; 1996 Jun; 87(11):4754-61. PubMed ID: 8639846
[TBL] [Abstract][Full Text] [Related]
11. Paradoxical effects of Auger electron-emitting (111)In-DTPA-NLS-CSL360 radioimmunoconjugates on hCD45(+) cells in the bone marrow and spleen of leukemia-engrafted NOD/SCID or NRG mice.
Bergstrom D; Leyton JV; Zereshkian A; Chan C; Cai Z; Reilly RM
Nucl Med Biol; 2016 Oct; 43(10):635-41. PubMed ID: 27497632
[TBL] [Abstract][Full Text] [Related]
12. AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML.
Pearce DJ; Taussig D; Zibara K; Smith LL; Ridler CM; Preudhomme C; Young BD; Rohatiner AZ; Lister TA; Bonnet D
Blood; 2006 Feb; 107(3):1166-73. PubMed ID: 16234360
[TBL] [Abstract][Full Text] [Related]
13. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice.
Cashman JD; Lapidot T; Wang JC; Doedens M; Shultz LD; Lansdorp P; Dick JE; Eaves CJ
Blood; 1997 Jun; 89(12):4307-16. PubMed ID: 9192753
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
[TBL] [Abstract][Full Text] [Related]
15. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells.
Pflumio F; Izac B; Katz A; Shultz LD; Vainchenker W; Coulombel L
Blood; 1996 Nov; 88(10):3731-40. PubMed ID: 8916937
[TBL] [Abstract][Full Text] [Related]
16. Proliferative status of primitive hematopoietic progenitors from patients with acute myelogenous leukemia (AML).
Guan Y; Hogge DE
Leukemia; 2000 Dec; 14(12):2135-41. PubMed ID: 11187903
[TBL] [Abstract][Full Text] [Related]
17. High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase.
Wang JC; Lapidot T; Cashman JD; Doedens M; Addy L; Sutherland DR; Nayar R; Laraya P; Minden M; Keating A; Eaves AC; Eaves CJ; Dick JE
Blood; 1998 Apr; 91(7):2406-14. PubMed ID: 9516140
[TBL] [Abstract][Full Text] [Related]
18. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.
Bonnet D; Dick JE
Nat Med; 1997 Jul; 3(7):730-7. PubMed ID: 9212098
[TBL] [Abstract][Full Text] [Related]
19. Expression of interleukin-3 receptor subunits on defined subpopulations of acute myeloid leukemia blasts predicts the cytotoxicity of diphtheria toxin interleukin-3 fusion protein against malignant progenitors that engraft in immunodeficient mice.
Yalcintepe L; Frankel AE; Hogge DE
Blood; 2006 Nov; 108(10):3530-7. PubMed ID: 16882709
[TBL] [Abstract][Full Text] [Related]
20. Long-term leukemia-initiating capacity of a CD34-subpopulation of acute myeloid leukemia.
Terpstra W; Prins A; Ploemacher RE; Wognum BW; Wagemaker G; Löwenberg B; Wielenga JJ
Blood; 1996 Mar; 87(6):2187-94. PubMed ID: 8630378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]